BMI View: Pakistan’s government is focused on increasing its pharmaceutical export capacity. However, we believe it would serve the country’s population better if the government invested in improving local pharmaceutical production capabilities to ensure patient access to domestically manufactured drugs rather than imported medicines. Headline Expenditure Projections ? Pharmaceuticals: PKR189.21bn (US$2.03bn) in 2012 to PRK209.43bn (US2.10bn) in 2013; +10.7% in local currency terms and +3.8% in US dollar terms. ? Healthcare: PKR515.60bn (US$5.52bn) in 2012 to PKR581.62bn (US$5.84bn) in 2013; +12.8% in local currency terms and +5.8% in US dollar terms.
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=127495.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/pakistan-pharmaceuticals-and-healthcare-report-q1-2014-market-report.html.
No comments:
Post a Comment